Company Filing History:
Years Active: 2009-2024
Title: Niva Yacov: Innovator in Cancer Research
Introduction
Niva Yacov is a prominent inventor based in Tel Aviv, Israel, known for her significant contributions to cancer research. With a total of 14 patents, she has made remarkable strides in developing methods for treating and preventing cancer.
Latest Patents
Among her latest patents is a groundbreaking invention related to Motile Sperm Domain Containing Protein 2 (MOSPD2). This patent discloses methods for treating, reducing the incidence of, or preventing various activities in cancer cells. It includes innovative approaches to inhibit cancer cell migration and metastasis, as well as methods to reduce tumor-associated macrophages (TAMs). Additionally, her work encompasses the development of inhibitors of MOSPD2, such as anti-MOSPD2 antibodies, and pharmaceutical compositions containing these inhibitors. Furthermore, she has developed methods for predicting, diagnosing, or prognosing cancer and its progression.
Career Highlights
Niva has worked with notable companies in the field, including Vascular Biogenics Ltd. and Immunewalk Therapeutics, Inc. Her expertise and innovative mindset have positioned her as a key player in the advancement of cancer therapies.
Collaborations
Niva has collaborated with esteemed colleagues, including Itzhak Mendel and Gideon Halperin, further enhancing her research and development efforts.
Conclusion
Niva Yacov's contributions to cancer research through her patents and collaborations highlight her as a leading inventor in the field. Her work continues to pave the way for innovative treatments and improved patient outcomes.